Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Peter Suzdak, PhD, the Company’s Chief Executive Officer, will present a company update at the 16th Annual BIO CEO & Investor Conference being held in New York City, NY. The presentation will be on Monday, February 10, 2014 at 2:30pm EST. A webcast of the presentation will be available on www.rexahn.com.
Help employers find you! Check out all the jobs and post your resume.
